Skip to main content
Displaying 1171 of 2857 articles.

How antibody therapy impacts COVID vaccines

People who receive monoclonal antibodies before vaccines may benefit from increased coverage, due to antibody feedback inhibition.

Research on rare genetic disease sheds light on a common head and neck cancer

Patients with Fanconi anemia have an elevated risk for squamous cell carcinoma, a highly aggressive head-and-neck cancer. New findings pinpoint the mechanisms linking the two conditions, and also shed new light on how smoking or drinking may elevate anyone’s cancer risk.

Cancer stem cells are fueled through dialogue with their environments

The findings suggest that many of the mutations in cancer may simply be setting in stone a path already forged by the tumor stem cell’s aberrant dialogue with its surroundings.

Ant pupae secrete fluid as "milk" to nurture young larvae

This newly discovered “social fluid” appears to unite ant colonies across developmental stages into one superorganism.

Promising new drug target for a rare liver cancer

Fibrolamellar carcinoma needs one specific mutation in order to thrive, and impeding it reduces tumor growth in mice.

New evidence of biochemical states and force working in concert

When an actin filament bends during cell movement, older actin deforms differently than newer actin, allowing regulatory proteins to tell the two states apart.

Mathematical modeling suggests counties are still unprepared for COVID spikes

If jurisdictions plan to share resources in advance, the study concludes, this could prevent one rare event from overwhelming a county or state.

Why some people are mosquito magnets

The female mosquito will hunt down any human, but some of us get bitten far more than others. The answer why may be hidden in our skin.

The brain cells that slow us down when we're sick

New study pinpoints the cluster of neurons that tell mice to eat, drink, and move around less when they're fighting bacterial infections.  

Common mutation linked to COVID mortality

Because three percent of the world population possesses these gene variants, the findings may have implications for hundreds of millions of individuals around the world.